CRMD CorMedix PE ratio, current and historical analysis

P/E ratio
6.69
Price (delayed)
$5.02
EPS (TTM)
$0.75

FullRatio score

?
Relative Growth 35
Relative Strength 17
Relative Valuation 88
Relative Profitability 83

Analysis summary

As of Nov 19, 2026, the CorMedix stock's PE ratio is 6.77. This takes into account the latest EPS of $0.75 and stock price of $5.08. The PE ratio has grown by 25% from its last 4 quarters average of 5.4.

CRMD PE ratio history

How has CRMD's PE ratio performed in the past

The PE ratio of CorMedix has averaged 9.42 over the last two years. The current P/E ratio of 6.77 is 28% lower than the historical average. Looking back at the last two years, CRMD's PE ratio peaked in the Mar 2025 quarter at 23.69, when the price was $6.16 and the EPS was $0.26. The lowest point was in the Mar 2026 quarter, when it reached 2.93 with a price of $6.79 and an EPS of $2.32.

Today
6.69
Average
9.42
Median
5.17
Minimum
2.93
Maximum
23.69

CorMedix PE ratio by year

Period PE ratio PE change Price EPS
2025 5.17 N/A $11.63 $2.25
2024 N/A N/A $8.1 -$0.3
2023 N/A N/A $3.76 -$0.91
2022 N/A N/A $4.22 -$0.74
2021 N/A N/A $4.55 -$0.75
2020 N/A N/A $7.43 -$0.77
2019 N/A N/A $7.28 -$1.8
2018 N/A N/A $6.45 -$1.51
2017 N/A N/A $2.51 -$3
2016 N/A N/A $7.65 -$3.25
2015 N/A N/A $10.15 -$2.9
2014 N/A N/A $9.55 -$4.8
2013 N/A N/A $6.2 -$3.45
2012 N/A N/A $3.6 -$1.5
2011 N/A N/A $1.41 -$2.9

CorMedix PE ratio by quarter (TTM)

Period PE ratio PE change Price EPS
Sep 2026 10.27 208.41% $7.7 $0.75
Jun 2026 3.33 13.65% $7.85 $2.36
Mar 2026 2.93 -43.33% $6.79 $2.32
Dec 2025 5.17 0.98% $11.63 $2.25
Sep 2025 5.12 -66.75% $11.63 $2.27
Jun 2025 15.4 -34.99% $12.32 $0.8
Mar 2025 23.69 N/A $6.16 $0.26
Dec 2024 N/A N/A $8.1 -$0.3
Sep 2024 N/A N/A $8.08 -$0.81
Jun 2024 N/A N/A $4.33 -$0.93
Mar 2024 N/A N/A $4.24 -$0.93
Dec 2023 N/A N/A $3.76 -$0.91
Sep 2023 N/A N/A $3.7 -$0.86
Jun 2023 N/A N/A $3.97 -$0.86
Mar 2023 N/A N/A $4.14 -$0.8

CRMD Price vs fair value

How does CRMD's price compare to its estimated fair value based on its growth

CRMD average PE ratio chart

What is the average PE ratio of CRMD for the past years

CRMD's current PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg
9.42
5-year avg
9.42
10-year avg
9.42
15-year avg
N/A

PE comparison

With a price to earnings (P/E) of 6.77, CRMD ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 23.48, CorMedix's price to earnings (P/E) is 71% lower.

CRMD PE vs peers

What is CRMD's PE ratio compared to its peers

Frequently asked questions

What is CorMedix's PE ratio?

The price to earnings ratio for CRMD stock as of Nov 19, 2026, stands at 6.77.

What is the 3-year average PE ratio for CorMedix (CRMD)?

Over the last 3 years, the average price to earnings ratio for CRMD stock is 9.42.

What is the 5-year average PE ratio for CorMedix (CRMD)?

Over the last 5 years, the average price to earnings ratio for CRMD stock is 9.42.

What is the highest PE ratio for CRMD?

The highest quarterly PE ratio in the last two years has been 23.69 and it was in the Mar 2025 quarter.

How does the current PE ratio for CRMD compare to its historical average?

CRMD's price to earnings ratio is currently 28% below its 2-year historical average.

Why is CorMedix's PE ratio so low?

A company with a lower PE ratio may indicate that the market has lower growth expectations for the company's future earnings.

How is CRMD's PE ratio calculated (CorMedix PE ratio formula)?

The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Nov 19, 2026), CorMedix's share price is $5.08. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2026 is $0.75. Therefore, CorMedix's PE ratio for today is 6.77. PE RATIO(6.77) = STOCK PRICE($5.08) / TTM EPS($0.75)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.